Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Lijecnicki Vjesnik|June 15, 2007
[Treatment of hairy cell leukemia with cladribine]Igor Aurer, Zdravko Mitrović, Jasminka Kovacević-Metelko, et al.Leukemia & Lymphoma|November 28, 2017
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendationsMartin Dreyling, Igor Aurer, Sergio Cortelazzo, et al.Lijecnicki Vjesnik|August 9, 2005
[Rituximab in the treatment of indolent non-Hodgkin's lymphoma]Igor Aurer, Zdravko Mitrović, Ivo Radman, et al.British Journal of Haematology|December 21, 2022
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trialsValeria Fiaccadori, Anouk Neven, Catherine Fortpied, et al.Medicina (Kaunas, Lithuania)|March 28, 2024
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)Ida Hude Dragičević, Sandra Bašić-Kinda, Helena Markotić, et al.Journal of Hematotherapy & Stem Cell Research|February 20, 2003
Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variantsMirna Sucić, Renata Zadro, Branka Burazer, et al.Hematology (Amsterdam, Netherlands)|July 12, 2018
Serum chitotriosidase: a circulating biomarker in polycythemia veraIvan Krecak, Velka Gveric-Krecak, Pavle Roncevic, et al.Acta Clinica Croatica|September 27, 2018
Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017Branimir Jakšić, Vlatko Pejša, Slobodanka Ostojić-Kolonić, et al.Biomedicines|February 24, 2024
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic DiseasesIgor Aurer, Ozren Jakšić, Sandra Bašić-Kinda, et al.Croatian Medical Journal|November 3, 2021
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic DiseasesSandra Bašić-Kinda, Karla Mišura Jakobac, Jasminka Sinčić-Petričević, et al.Pageof 7